VSTM Verastem, Inc.
$9.84
Verastem, Inc. (VSTM) Earnings News
Earnings press releases, previews and reviews for Verastem, Inc. (VSTM), newest first. Our most recent is preview: Verastem Must Prove Its Commercial Rebound Is Real as G12D Hopes Lift the Stock.
Wednesday
October 28, 2026
9:40 PM ET
Verastem Must Prove Its Commercial Rebound Is Real as G12D Hopes Lift the Stock
Earnings Whispers · Preview
Thursday
October 22, 2026
7:30 AM ET
Verastem Oncology to Report Third Quarter 2026 Financial Results on November 5, 2026
Thursday
August 6, 2026
4:01 PM ET
Verastem Oncology Reports Second Quarter 2026 Financial Results and Highlights Recent Business Updates
Thursday
July 23, 2026
7:30 AM ET
Verastem Oncology to Report Second Quarter 2026 Financial Results on August 6, 2026
Wednesday
June 17, 2026
7:30 AM ET
Verastem Oncology Announces Positive Updated Results from RAMP 205 Evaluating Avutometinib Plus Defactinib in Combination with Standard-of-Care Chemotherapy in First-Line Metastatic Pancreatic Cancer
Thursday
May 7, 2026
4:01 PM ET
Verastem Oncology Reports First Quarter 2026 Financial Results and Highlights Recent Business Updates